The White House announced 36 new project commitments under its ongoing Cancer Moonshot oncology initiative, including an ambitious project to create an open liquid-biopsy database and a NASA-NCI collaboration to explore the benefits of particle-beam radiotherapy.
The latest public- and private-sector commitments under the White House's Cancer Moonshot initiative include projects focused on liquid biopsy and other diagnostic tools for cancer diagnosis and next-generation radiation oncology technology to treat cancer.
Molecular diagnostics and radiation therapy are two fields medtech advocates have been pushing to attract attention by the broad-based initiative...
Paul Campbell, chief regulatory officer at HealthAI, emphasizes existing regulations for AI in healthcare should not be overlooked as new regulations are developed.
CEO Alexandre Chau told Medtech Insight that the Middle East and Africa presented the ideal mix of market potential, physician training opportunities, and regulatory readiness when the company was considering expansion markets beyond Europe and the US.
A recent approval from the US FDA allowing Boston Scientific to broaden its labeling for its pulse field ablation system means more patients with one type of AFib will have access to a promising new treatment.
